Recent News

Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones

Aug 10, 2026, 10:47:51 AM

Submitted First Module of Modular PMA Application to FDA

Envoy Medical Surpasses Three-Month Visit Milestone for All 56 Patients in Pivotal Clinical Trial

Jul 21, 2026, 8:33:50 AM

White Bear Lake, Minnesota--(Newsfile Corp. - July 21, 2026) -Envoy Medical® Inc.(NASDAQ: COCH) ("En...

Envoy Medical Reports Positive 12-Month Data Showing Continued Improvement in Speech Perception in Study of First-of-Its-Kind Fully Implanted Cochlear Implant

Jul 14, 2026, 8:36:08 AM

Mean CNC word recognition scores for Stage 1 cohort improved to 53.2% at 12 months from 15.2% pre-im...

Envoy Medical Submits First Module of Modular Premarket Approval Application to the U.S. Food and Drug Administration for Breakthrough-Designated Device

Jun 30, 2026, 8:36:30 AM

Modular Regulatory Strategy Creates Defined Milestone Cadence, Enables Earlier FDA Engagement, and S...

Envoy Medical Terminates At-the-Market (ATM) Equity Facility

Jun 25, 2026, 9:01:38 AM

Termination Reflects Company's Confidence in Current Capital Position

Envoy Medical to Present at Investor Conferences on June 25th

Jun 18, 2026, 10:18:13 AM

White Bear Lake, Minnesota--(Newsfile Corp. - June 18, 2026) -Envoy Medical® Inc. (NASDAQ: COCH) ("E...

Envoy Medical to Present at Planet MicroCap Conference Las Vegas on June 16th-18th

Jun 4, 2026, 9:09:53 AM

White Bear Lake, Minnesota--(Newsfile Corp. - June 4, 2026) -Envoy Medical® Inc. (NASDAQ: COCH), a h...

Blue background with sound wave and Press Release title

Envoy Medical Announces New Patents Expanding Intellectual Property Portfolio in Fully Implanted Hearing Technology

May 20, 2026, 9:19:28 AM

Australian and European Patent Offices Grant the Company Four Patents Relating to Key Innovations in...

Envoy Medical Reports Landmark Accomplishments, Advancing Toward FDA Approval of First-of-Its-Kind Fully Implanted Cochlear Implant

May 11, 2026, 8:44:26 AM

Company Completes Historic Trial Enrollment, Secures Transformational Financing, and Sees Promising ...

Envoy Medical Highlights First Clinical Data Presentations from Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant

Apr 28, 2026, 8:34:46 AM

Positive Initial 6-Month Data from First 10 Patients and Improvements in Speech Understanding and Qu...

*The materials and resources presented are intended to be an educational resource for general purposes only. They are not intended to constitute medical or business advice or in any way replace the independent medical judgment of a trained and licensed physician. Each person’s situation is unique and risks, outcomes, experience and results may vary. CAUTION: The fully implanted Acclaim Cochlear Implant is an investigational device. Limited by federal (or United States) law to investigational use.

**See Important Information here.

News Room